Xavier Charest-Morin Selected Research

Xavier Charest-Morin Research Topics

3	Hereditary Angioedemas 08/2020 - 01/2018
3	Neoplasms (Cancer) 01/2017 - 01/2013
2	Inflammation (Inflammations) 09/2021 - 02/2020
2	Angioedema 08/2020 - 06/2016
1	Gout 09/2021
1	Arthritis (Polyarthritis) 09/2021
1	Edema (Dropsy) 02/2020
1	Infections 02/2020
1	Hypersensitivity (Allergy) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 03/2015
1	Melanoma (Melanoma, Malignant) 01/2013
1	Tics (Tic) 04/2012

3	KininsIBA 01/2018 - 03/2015
2	icatibantIBA 08/2020 - 02/2020
2	BradykininIBA 08/2020 - 01/2018
1	CollagenIBA 09/2021
1	LigandsIBA 08/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2020
1	Peptides (Polypeptides)IBA 02/2020
1	CytokinesIBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	Type C PhospholipasesIBA 02/2020
1	Fibrinolysin FDA Link 01/2018
1	ProdrugsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2017
1	Antimitotic AgentsIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 06/2016
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2014
1	CC ChemokinesIBA 01/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013
1	Peroxidase (Myeloperoxidase)IBA 01/2013
1	B 10380IBA 04/2012
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2012
1	2,5-dichloro-4-bromophenol (B 2)IBA 04/2012
1	B 9430IBA 04/2012
1	RacivirIBA 04/2012
1	lysyllysine (Lys-Lys)IBA 04/2012

2	Drug Therapy (Chemotherapy) 01/2017 - 10/2014